Cataract surgery in behçet's disease patients one week after infliximab administration

Case Reports in Ophthalmology

Volumn 2, Issue 2, 2011, Pages 176-178

  Handa, Tsuneaki ^a   Tsunekawa, Hinako ^a   Zako, Masahiro ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Beh et's disease; Cataract surgery; Infection; Infliximab; Tumor necrosis factor a

Indexed keywords

INFLIXIMAB; LEVOFLOXACIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION; BEHCET DISEASE; CASE REPORT; CATARACT; CATARACT EXTRACTION; EYE INFLAMMATION; HUMAN; LENS IMPLANTATION; MALE; PEROPERATIVE COMPLICATION; PHACOEMULSIFICATION; POSTERIOR EYE CHAMBER; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; VISUAL ACUITY;

EID: 79958707294     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000329091     Document Type: Article

References (10)

1. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN: Effect of infliximab on sightthreatening panuveitis in Behçet's disease. Lancet 2001;358:295-296. (Pubitemid 32738970)
2. Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G: Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol 2004;31:1362-1368. (Pubitemid 38879203)
3. Ellerin T, Rubin RH, Weinblatt ME: Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2003;48:3013-3022. (Pubitemid 37409310)
4. Ishida M, Kataoka T, Niwa K, Iwaki M, Zako M: Efficient penetration into aqueous humor by administration of oral and topical levofloxacin. J Ocul Pharmacol Ther, in press.
5. Noda E, Yamanishi S, Shiraishi A, Ohashi Y: Cataract surgery under infliximab therapy in a patient with Behçet's disease. J Ocul Pharmacol Ther 2009;25:467-470.
6. Sakai T, Kanetaka A, Noro T, Tsuneoka H: Intraocular surgery in patients receiving infliximab therapy for Behçet disease. Jpn J Ophthalmol 2010;54:360-361.
7. Sugita S, Yamada Y, Mochizuki M: Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease. Br J Ophthalmol 2011;95:549-552.
8. Svenson M, Geborek P, Saxne T, Bendtzen K: Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies. Rheumatology (Oxford) 2007;46:1828-1834. (Pubitemid 350168300)
9. Komano Y, Tanaka M, Nanki T, Koike R, Sakai R, Kameda H, Nakajima A, Saito K, Takeno M, Atsumi T, Tohma S, Ito S, Tamura N, Fujii T, Sawada T, Ida H, Hashiramoto A, Koike T, Ishigatsubo Y, Eguchi K, Tanaka Y, Takeuchi T, Miyasaka N, Harigai M: Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety. J Rheumatol, in press.
10. Momohara S, Kawakami K, Iwamoto T, Yano K, Sakuma Y, Hiroshima R, Imamura H, Masuda I, Tokita A, Ikari K: Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol, in press.